Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioCryst Pharmaceuticals, Inc. (NQ: BCRX)
1.700 USD  +0.020 (+1.19%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about BioCryst Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 Next >
BioCryst’s Partner Shionogi Receives Approval for Pediatric Use Of Peramivir in Japan
October 27, 2010
from Business Wire News Releases
BioCryst to Present at Oppenheimer Healthcare Conference
October 25, 2010
from Business Wire News Releases
BioCryst to Present New Clinical & Virologic Data for I.V. Peramivir at the 48th Annual IDSA Meeting
October 21, 2010
from Business Wire News Releases
BioCryst to Present New Clinical & Virologic Data for I.V. Peramivir at the 48th Annual IDSA Meeting
October 21, 2010
from Business Wire News Releases
BioCryst Ranked Number Five in Deloitte’s 2010 Technology Fast 500™ Program for Fastest Growing Companies in North America
October 20, 2010
from Business Wire News Releases
BioCryst Ranked Number Five in Deloitte’s 2010 Technology Fast 500™ Program for Fastest Growing Companies in North America
October 20, 2010
from Business Wire News Releases
BioCryst Pharmaceuticals to Announce Third Quarter 2010 Financial Results on October 28, 2010
October 18, 2010
from Business Wire News Releases
BioCryst Pharmaceuticals to Announce Third Quarter 2010 Financial Results on October 28, 2010
October 18, 2010
from Business Wire News Releases
BioCryst to Present At JMP Securities Healthcare Conference
September 21, 2010
from Business Wire News Releases
BioCryst Reports Positive Results From A Phase 2 Study Of BCX4208 Combined with Allopurinol in Patients with Gout
September 16, 2010
Top-line Results to be Discussed During Investor Day Meeting Today Read More
from Business Wire News Releases
BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting
September 15, 2010
from Business Wire News Releases
BioCryst Reports Results from Two Forodesine Oncology Studies
September 15, 2010
Top-line results from pivotal study in patients with relapsed or refractory cutaneous T-cell lymphoma Read More
from Business Wire News Releases
BioCryst to Host & Webcast Investor Day on September 16, 2010
September 08, 2010
from Business Wire News Releases
BioCryst’s Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea
August 16, 2010
from Business Wire News Releases
BioCryst Reports Second Quarter 2010 Financial Results and Provides Corporate Update
August 05, 2010
from Business Wire News Releases
BioCryst Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
July 27, 2010
from Business Wire News Releases
BioCryst Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com
June 30, 2010
from GlobeNewswire News Releases
BioCryst Initiates a Phase 2 Study of BCX4208 Alone and in Combination with Allopurinol in Patients with Gout
June 01, 2010
from Business Wire News Releases
BioCryst to Present at Jefferies 2010 Global Life Sciences Conference
May 27, 2010
from Business Wire News Releases
Skymark Research Initiates Independent Research Coverage on BioCryst Pharmaceuticals, Inc.
May 11, 2010
from GlobeNewswire News Releases
BioCryst To Present at Two Upcoming Investor Conferences
May 03, 2010
from Business Wire News Releases
BioCryst Reports First Quarter 2010 Financial Results and Provides Corporate Update
April 28, 2010
from Business Wire News Releases
BioCryst Reports Positive Results from Part One of Its Phase 2a Study of BCX4208 in Patients with Gout
April 28, 2010
from Business Wire News Releases
BioCryst Pharmaceuticals to Announce First Quarter 2010 Financial Results on April 28, 2010
April 21, 2010
from Business Wire News Releases
BioCryst to Speak at RBC Healthcare Conference
February 18, 2010
from PR Newswire
BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update
February 04, 2010
from PR Newswire
BioCryst To Present At 12th Annual BIO CEO & Investor Conference
February 01, 2010
from PR Newswire
BioCryst's Partner Shionogi Launches Peramivir In Japan Under The Name 'RAPIACTA'
January 26, 2010
from PR Newswire
BioCryst Pharmaceuticals to Announce Fourth Quarter 2009 Financial Results on February 4, 2010
January 21, 2010
from PR Newswire
Emerging Healthcare Solutions Sees Aggressive Business Model Expansion
January 19, 2010
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here